Back to search results

Educational Video Series for Women in Breast Cancer Treatment

This study is looking at whether an educational video series can help women with newly diagnosed breast cancer feel more confident talking about sexual health with their doctors. It also wants to see if the videos can help reduce things that make it hard to have these conversations. About 200 women will either get access to these videos or receive their usual care. You would need to be at least 18 years old, a female assigned at birth, and able to read English or Spanish. You also need a recent diagnosis of Stage 1-III invasive breast cancer and be currently receiving treatment. The study is currently unclear on its recruitment status.

Study design
This study will randomly assign about 200 participants to either receive access to an online sexual health video series or receive standard care.
What's involved
You would complete surveys at the beginning of the study and then every two months for six months. Some participants will also be asked to do interviews.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for six months, with surveys completed at baseline, 2 months, 4 months, and 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07434817

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
University of Colorado, Denver
~200 participants
Updated 2026-02-27 on ClinicalTrials.gov
What's tested:Sexual Health Educational Video SeriesStandard Care (in control arm)

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant self-efficacy discussing sexual health with breast cancer providers
Measured over Baseline, 2 months, 4 months, 6 months
+1 more outcome measured

Conditions

Breast Cancer Females
Newly Diagnosed Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

4 sites across 1 states
Colorado4

Study leadership

  • Sarah Tevis · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Who to contact

Sarah Leslie, MPH
[email protected]
303-724-8995
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Provision to sign and date the consent form.
Stated willingness to comply with all study procedures and be available for the duration of the study.
Age minimum 18
Be a female as assigned on birth certificate
Ability to read and speak English or Spanish
A recent diagnosis of Stage 1-III invasive breast cancer and receiving treatment for breast cancer at the University of Colorado or Denver Health breast center(s).

Exclusion

Age less than 18 years old
Stage 0 or Stage IV breast cancer
Prior breast cancer diagnosis
Non-breast cancer diagnoses
Prior exposure to anti-hormone therapy, chemotherapy, or radiotherapy not related to breast cancer

What this trial measures

  • Participant self-efficacy discussing sexual health with breast cancer providersBaseline, 2 months, 4 months, 6 months

    Changes in participant self-efficacy to discuss sexual health with breast cancer providers will be assessed using the Perceived Efficacy in Patient-Physician Interactions (PEPPI-5), administered at enrollment and every two months over a six-month period. The PEPPI-5 is a 5-item measure scored on a 5-point Likert scale, with higher scores indicating greater perceived self-efficacy in communicating with healthcare providers.

  • Perceived barriers to discussing sexual health with breast cancer providersBaseline, 2 months, 4 months, 6 months

    Measured using the 13-item Barriers to Sexual Health Communication (BSHC) scale. Items are rated on a 5-point Likert scale; higher scores reflect greater perceived communication barriers.